drugset / Trial / NCT05305872
Gandouling in the Treatment of Wilson's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy and safety of gandouling tablet in the treatment of clinical symptoms of Wilson's diasease.
Timeline
- Start
- 2023-01-01
- Primary completion
- 2023-03-01
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zinc gluconate | Small molecule | — | — |